Product Types

Sai Life Sciences offers comprehensive development and commercial manufacturing of small molecule APIs across diverse therapeutic areas. Our manufacturing network comprises 80 production trains with a total installed capacity of 700 KL, featuring reactor sizes ranging from 250 L to 12,000 L.

We operate with multiple material-of-construction (MOC) options —Stainless Steel, Glass-Lined, and Hastelloy reactors — enabling flexibility across a wide range of chemistries. Advanced capabilities include preparative HPLC purification and lyophilization, supporting complex molecules requiring high purity and specialized isolation techniques.

This infrastructure enables seamless scale-up from clinical to commercial supply with regulatory compliance for global markets.

Sai Life Sciences operates a dedicated high-containment facility for OEB-5 compounds, designed for the safe handling and manufacture of highly potent APIs. The facility is equipped with reactor sizes ranging from 50 L to 1,000 L, with Stainless Steel, Glass-Lined, and Hastelloy MOCs to support diverse synthetic routes.

The infrastructure is engineered to ensure stringent operator protection, cross-contamination control, and regulatory compliance, enabling safe and reliable supply of potent compounds from clinical development through commercial scale.

We support the development and GMP manufacturing of cytotoxic APIs within facilities designed with stringent containment controls, dedicated production areas, and engineered safety systems for handling highly toxic oncology compounds.

Our infrastructure incorporates segregated manufacturing suites, controlled material and personnel flows, and validated cleaning procedures to ensure regulatory compliance, product integrity, and operator safety. This enables safe scale-up and reliable supply for global oncology programs.

Sai Life Sciences operates a dedicated manufacturing site for Animal Health APIs, designed to deliver cost-effective and scalable production for regulated and semi-regulated markets.

The facility includes ISO-8 cleanroom environments and reactor capacities ranging from 250 L to 3,000 L, supporting efficient manufacturing of veterinary APIs with robust quality systems and regulatory compliance aligned to global animal health standards.

We offer development and manufacturing of liquid phase peptides, supported by scalable reactor infrastructure and purification capabilities. Our expertise enables efficient synthesis, isolation, and quality control of mid-length and specialty peptides for clinical and commercial applications.

Sai Life Sciences has demonstrated experience in the commercial-scale manufacturing of GalNAc linkers, supporting targeted drug delivery platforms including oligonucleotide therapeutics and ADC applications.

Our capabilities span complex multi-step synthesis, impurity control, and scale-up, ensuring consistent quality and supply reliability for advanced therapeutic modalities.

We have strong experience in manufacturing both custom and commodity amidites at scale, supporting oligonucleotide synthesis programs.

Our facilities are designed to handle sensitive chemistries and moisture-sensitive products under controlled humidity conditions, ensuring product stability, high purity, and batch-to-batch consistency for GMP supply.

Sai Life Sciences supports the development and manufacturing of specialty lipids for advanced drug delivery systems. Our multipurpose infrastructure and chemistry expertise enable scalable synthesis and purification of lipid components for clinical and commercial supply.

We have extensive experience in manufacturing Registered Starting Materials (RSMs) and GMP intermediates at commercial scale, including multi-ton production volumes.

Our multipurpose facilities, supported by large-scale reactor capacity and robust quality systems, enable secure, compliant, and cost-efficient supply — strengthening customers’ regulatory filings and supply chain resilience.